How are patients' preferences for anti-TNF influenced by quality of life? A discrete choice experiment in Crohn's disease patients.

Solène Brunet-Houdard Fanny MonmousseauGeoffrey BerthonVéronique Des GaretsDavid LaharieLaurence PiconGinette FotsingDany GargotCloé CharpentierAnthony BuissonCaroline Trang-PoissonNina DibEmmanuel RuschAlexandre Aubourgnull null

Published in: Scandinavian journal of gastroenterology (2022)

HRQoL level changed patients' preferences for the anti-TNF treatment. The results suggest the need to optimise the management of IV infusions in the hospital and reinforce the importance of patient-reported outcome measures (PROMS) as a common practice to improve shared medical decision making.

Keyphrases

end stage renal disease
patient reported
newly diagnosed
ejection fraction
chronic kidney disease
decision making
patient reported outcomes
rheumatoid arthritis
peritoneal dialysis
prognostic factors
primary care
combination therapy